sofidexFor patientsAre you a clinician? Clinical site

Meds & supplements  ›  Pimavanserin

Medicine

Pimavanserin

NUPLAZID ® is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
NUPLAZID ® is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
Do not take if
  • Pimavanserin is contraindicated in patients with a history of a hypersensitivity reaction to pimavanserin or any of its components.
  • Rash, urticaria, and reactions consistent with angioedema (e.g., tongue swelling, circumoral edema, throat tightness, and dyspnea) have been reported [ see Adverse Reactions ].

What it is used for

Pimavanserin capsule is indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.

Side effects, and when to stop

The following serious adverse reactions are discussed elsewhere in the labeling:

  • Increased Mortality in Elderly Patients with Dementia-Related Psychosis
  • QT Interval Prolongation

Who should not take it

Pimavanserin is contraindicated in patients with a history of a hypersensitivity reaction to pimavanserin or any of its components. Rash, urticaria, and reactions consistent with angioedema (e.g., tongue swelling, circumoral edema, throat tightness, and dyspnea) have been reported [ see Adverse Reactions ].

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Pimavanserin; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/pimavanserin

APA 7th

sofidex. (2026, August 3). Pimavanserin. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/pimavanserin

AMA 11th

Pimavanserin. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/pimavanserin

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.